Related Experiment Video

Updated: Feb 23, 2026

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

3.5K

Small heterodimer partner protects against osteoarthritis by inhibiting IKKβ/NF-κB-mediated matrix-degrading enzymes

Eun-Jung Kang1, Jung-Ran Noh1, Jae-Hoon Kim2

  • 1Laboratory Animal Resource & Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.

Nature Communications
|February 21, 2026
PubMed

Insights

Small heterodimer partner (SHP, NR0B2) acts as a protective factor in osteoarthritis (OA) by reducing cartilage degradation. Boosting NR0B2 levels may offer a new gene therapy approach for treating this common joint disease.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Orthopedics

Background:

  • Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by cartilage destruction.
  • Current treatments for OA lack disease-modifying capabilities, highlighting the need for novel therapeutic targets.

Purpose of the Study:

  • To investigate the role of orphan nuclear receptor small heterodimer partner (SHP, NR0B2) in osteoarthritis pathogenesis.
  • To explore NR0B2 as a potential therapeutic target for OA.

Main Methods:

  • Analysis of NR0B2 expression in OA patient cartilage.
  • Utilizing global and chondrocyte-specific Nr0b2 knockout mouse models to study OA progression.
  • Employing adeno-associated virus (AAV)-mediated gene delivery for NR0B2 overexpression in mouse knee joints.
  • Investigating the molecular mechanism involving IKKβ kinase activity and NF-κB signaling.

Main Results:

  • NR0B2 expression was significantly downregulated in OA cartilage.
  • Nr0b2 deficiency in mice exacerbated OA-related pain and structural damage, increasing matrix metalloproteinase (MMP)-3 and MMP-13 levels.
  • Overexpression of NR0B2 in mice conferred protection against OA development.
  • NR0B2 was found to inhibit IKKβ kinase activity, thereby downregulating NF-κB signaling.

Conclusions:

  • NR0B2 plays a crucial chondroprotective role in OA by regulating the expression of matrix-degrading enzymes through the IKKβ/NF-κB pathway.
  • Gene therapy targeting NR0B2 represents a promising therapeutic strategy for osteoarthritis.

More Related Videos

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

4.6K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.3K